[Skip to Navigation]
[Skip to Navigation Landing]
News From the Food and Drug Administration
January 3, 2017

Relief for Painful Intercourse

JAMA. 2017;317(1):18. doi:10.1001/jama.2016.19077

The FDA has approved a medication to help relieve the moderate to severe pain some women may experience during sexual intercourse because of vulvar and vaginal atrophy (VVA) after menopause.

The drug, marketed as Intrarosa, is the first FDA-approved product containing the active ingredient prasterone, also known as dehydroepiandrosterone (DHEA). It is used as a once-daily vaginal insert.